Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
Alzheimer's Variant Imaging Study (ADVISe)
Sponsor: NIH
Enrolling: Male and Female Patients
Clinic Visits: 4
IRB Number: AAAS7810
U.S. Govt. ID: NCT04576793
Contact: Galen Ziaggi: 212-305-6736 / gfz2102@cumc.columbia.edu
Additional Study Information: The purpose of this study is to determine how inflammation is related to changes in the brain that occur during the progression of Alzheimer's disease. If you are eligible for this study, we will ask you to complete 3-4 study visits over the course of about 5 months. Participation includes memory testing, a blood draw, MRI, PET scans, and a lumbar puncture (spinal tap). You will be compensated $750 plus travel costs. After 2 years, we will invite you to return for follow-up.
James Noble, MD, MS
Do You Qualify?
Are you (or the patient) 50 years of age or older? Yes No
Do you (or the patient) have Alzheimer's disease? Yes No
Do you (or the patient) have written and oral fluency in English? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Galen Ziaggi